Articles by : Rich Daly, Editor in Chief

Citing U.S. Supreme Court Decision, Health System Sues Medicare Advantage Plan for Past 340B Payments

February 15, 2024 Rich Daly, Editor in Chief Views

An Alabama health system is suing Humana over past reduced 340B rates paid by its Medicare Advantage plans.

Baptist Health of Alabama sued Humana in federal court over the lack of repayment by the company’s Medicare Advantage (MA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

PhRMA Map Highlights State-Specific Extent of Hospitals’ Contract Pharmacy Usage

February 15, 2024 Rich Daly, Editor in Chief Views

Nicole Longo, a spokesperson for PhRMA, said a new state-specific map of 340B contract pharmacy usage illuminates the "radical transformation" of the program.

The leading drugmaker advocacy group issued a data-linked map that aims to highlight the extent of contract pharmacy usage by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

User Fees in Senate Group of Six Bill Raise Provider Concerns But Unlikely To Scuttle Bill

February 13, 2024 Rich Daly, Editor in Chief Views

William von Oehsen, principal at the law firm Powers, said the SUSTAIN ACT is "not going to live or die based on the user fee."

The inclusion of a provision in draft 340B reform legislation creating “user fees” on 340B covered entities (CEs) is likely [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Pans NEJM Study on 340B Price Mark Ups, Lead Author Fires Back

February 13, 2024 Rich Daly, Editor in Chief Views

Aimee Kuhlman, vice president of advocacy and grassroots for AHA, co-wrote a blog post that criticized an NEJM study on 340B price mark ups.

The country’s largest hospital advocacy organization has leveled several challenges to a high-profile January study that concluded 340B hospitals had [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Consulting Firm Visante Garners PE Investment, Makes Several Promotions

February 13, 2024 Rich Daly, Editor in Chief Views

Steve Rough, the new CEO of Visante, said the health system consulting firm has received its first private equity investment.

Health system consulting firm Visante on Monday received a first-ever investment from a private equity firm and undertook planned changes [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Key 2024 Priorities Include Contract Pharmacy Protections Among Other 340B Goals

February 8, 2024 Rich Daly, Editor in Chief Views

American Hospital Association seal on interior office wall

The American Hospital Association and other major hospital groups have placed multiple 340B program goals on their 2024 advocacy agendas.

Several national hospital groups name 340B contract pharmacy protections, among other 340B goals, in their 2024 advocacy priorities. The American [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Broad Stakeholder Support for Senate Group of Six Draft 340B Overhaul

February 6, 2024 Rich Daly, Editor in Chief Views

The “Group of Six” is expected to announce this week that it plans to release the SUSTAIN Act by the end of the year.

Recently released draft congressional legislation to reform the 340B program has drawn positive initial reactions from across the range of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Reaches Record Levels in 2023

February 6, 2024 Rich Daly, Editor in Chief Views

Jackson Hammond of the American Action Forum said financial pressure was a driver of PhRMA's increased lobbying efforts.

Lobbying on 340B issues reached a record level in 2023, according to annual tallies of congressional lobbying disclosures. That flurry [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Posts 340B Refund Notice on High-Revenue Asthma Treatment

February 6, 2024 Rich Daly, Editor in Chief Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

Drugmaker GlaxoSmithKline has posted another refund notice to 340B providers related to purchases of its high-earning asthma drugs. A Jan. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Highly Anticipated Draft 340B Bill Released by Bipartisan Senate Gang of Six

February 2, 2024 Rich Daly, Editor in Chief Views

The “Group of Six” is expected to announce this week that it plans to release the SUSTAIN Act by the end of the year.

After more than six months of long meetings with stakeholders, a bipartisan group of six senators released draft legislation Friday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live